Dr. Graham graduated with BPharm from Chelsea College, PhD from King’s College London and Doctor of Science in 1997, for “Materials characterisation of importance to drug delivery”. In 2012 he passed the IoD Certificate and Diploma in Company Direction. Professor Buckton is a fellow of the Royal Pharmaceutical Society, Royal Society of Chemistry, AAPS and APSGB, he is a Freeman of the City of London. He joined the staff of King’s College London as lecturer in pharmacy in 1984. In 1989 he moved to the School of Pharmacy, University of London where he progressed through the positions of Lecturer, Senior Lecturer, Reader and Professor and was the Head of Department and Professor of Pharmaceutics. Until Sept 2012 he was Chief Executive Officer of Pharmaterials Ltd which is the contract research company that he founded in 2000. He served a 10 year term as Editor of the International Journal of Pharmaceutics and has recently served, on the editorial boards of Pharmaceutical Research, The AAPS Journal and the steering committee for the Excipients Handbook. Was the first Chairman of the Academy of Pharmaceutical Sciences of GB and a past Chairman of the Pharmaceutical Sciences Group of the Royal Pharmaceutical Society of Great Britain. Was past Chairman of the Chemistry, Pharmacy and Standards sub-committee of the Committee on Safety of Medicines and a member of the CSM, is a member of the CPS TAG of the Commission on Human Medicines. Was Science Chairman of the British Pharmaceutical Conference 2003. Was a British Pharmacopoeia Commissioner and contributes to Ph Eur, USP and EMEA working parties.

His research relates to the study of physical properties of materials in relation to drug delivery. This involves extensive study of the amorphous state, it structure, changes with time, and impact on materials processing for inhalation delivery. Research also relates to poorly soluble drug delivery systems. Tools used include thermal analysis and surface analysis. I am the UCL School of Pharmacy Director for the EPSRC Centre for Doctoral Training in Targeted Therapeutics with the University of Nottingham and AZ, Alliance Boots, GSK, Pfizer and Quotient.